SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Drug Delivery: Top Headlines

In nano-rod we trust: magnetic pulse tech breakthrough for cancer drug delivery

Nanoparticles as medical devices and for drug delivery

17-Dec-2014 - A magnetic pulse technology that can align and push nanoparticles to points distant to magnet surfaces could finally make magnets attractive for deep tissue drug delivery according to researchers.

Related news

News in brief

Sosei looks to $23bn peptide market with acquisition of tech firm Jitsubo

15-Dec-2014 - Sosei Group Corporation is looking to peptides to replenish its pipeline through the $70m acquisition of technology firm Jitsubo.

AstraZeneca shutting asthma drug plant as pipeline shifts to biologics

12-Dec-2014 - AstraZeneca has continued the Big Pharma trend away from small molecule blockbusters and towards a biologics-heavy pipeline, announcing the closure of its Pulmicort facility in Massachusetts.

Axim to build Dutch facility for cannabinoid-based chewing gum drug

04-Dec-2014 - A company developing a pharmaceutical chewing gum containing cannabinoids extracted from marijuana has announced plans to build a manufacturing facility in the Netherlands.

Investment in oral insulin firm could aid entry to lucrative China market

04-Dec-2014 - Oral insulin developer Oramed Pharmaceuticals is looking at China’s growing diabetes problem following a $5m investment from Guangxi Wuzhou Zhongheng.

Advanced aspirin aspirations ailing? Sanofi and Pozen terminate deal

02-Dec-2014 - Sanofi and Pozen have dissolved a $35m ‘advanced aspirin’ partnership less than a month before the US FDA decides whether to approve the new drug. 

Happy Thanksgiving for GSK with FTC approval of Novartis vaccine biz

27-Nov-2014 - Just in time for the holidays, GSK can ‘give thanks’ to the US Federal Trade Commission (FTC) which has approved the $7bn acquisition of Novartis’ vaccine business.

Recipharm adds French plant and drug delivery tech in strategic deal with Flamel

27-Nov-2014 - Recipharm will acquire a facility and add technologies including spray granulation and spray coating as part of a “truly strategic” collaboration with France-based Flamel Technologies. 

Drug Delivery: Featured news

Spotlight

Axim to build Dutch facility for cannabinoid-based chewing gum drug

Axim to build Dutch facility for cannabinoid-based chewing gum drug

A company developing a pharmaceutical chewing gum containing cannabinoids extracted from marijuana has announced plans to build...

Two INDs or not two INDs? Unanswered questions in China draft MRCT guide

Two INDs or not two INDs? Unanswered questions in China draft MRCT guide

Drugmakers that include China in multi-regional trials will need to submit dossiers filed elsewhere for review, open...

Advanced aspirin aspirations ailing? Sanofi and Pozen terminate deal

Advanced aspirin aspirations ailing? Sanofi and Pozen terminate deal

Sanofi and Pozen have dissolved a $35m (Eur28m) ‘advanced aspirin’ partnership less than a month before the...

Want to relocate to Asia? What pharma recruiters really look for

Want to relocate to Asia? What pharma recruiters really look for

Singaporean companies are looking for scientists, while China and India need execs – but don’t count on...

Chinese excipient market set to more than double by 2017

Chinese excipient market set to more than double by 2017

With more than 90 excipient manufacturers in China dedicated to the pharma industry, the country expects its...

BASF sells Norway plant, focuses on pharma grade omega-3 products

BASF sells Norway plant, focuses on pharma grade omega-3 products

BASF says the supply of API to GSK and other pharma customers will not be affected by...

Key Industry Events

 

Access all events listing

Our events, Events from partners...

Products